Expand Content

Cancer Clinical Trials Results

A03120114-332 Phase III Trial fo Enzalutamide versus Enzalutamide, Abiraterone and Prednisone for castration resistant metastatic prostate cancer Beachwood, Fairview, Florida Weston, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, South Pointe, Strongsville, Wooster Phase 3Prostate
CALGB 70807FLA11-071 The men’s eating and living (meal) study: a randomized trial of diet to alter disease progression in prostate cancer patients on active surveillance Florida WestonStage 1, Stage 1A, Stage 1B, Stage 1C, Stage 2, Stage 2A Prostate
CALGB 90203FLA9033 A randomized phase III study of neo-adjuvant docetaxel and androgen deprivation prior to radical prostatectomy versus immediate radical prostatectomy in patients with high-risk, clinically localized prostate cancer. Florida WestonStage 1, Stage 1A, Stage 1B, Stage 2, Stage 2A, Stage 2B, Stage 3, Stage 3APhase 3Prostate
CASE 1281213-797 A Phase 2 Study of Enzalutamide in patients with High-risk Prostate Cancer who have undergone local definitive therapy with Radical Prostatectomy Main Campus Phase 2Prostate
CASE 781313-661 The origins of resistance to hormonal therapy in advanced prostate cancer Main Campus  Prostate
OCOP 181414-1317 A Multinational, Randomised, Double-Blind, Placebo-Controlled, Phase III Efficacy and Safety Study of ODM-201 in Men with High-Risk Non- Metastatic Castration-Resistant Prostate Cancer (ARAMIS) Main Campus Phase 3Prostate
RTOG 0534CC657 Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy Fairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Strongsville, Wooster Phase 3Prostate
RTOG 0924CC11-033 Androgen deprivation therapy and high dose radiotherapy with or without whole-pelvic radiotherapy in unfavorable intermediate or favorable high risk prostate cancer: a phase III randomized trial Florida WestonStage 1C, Stage 2, Stage 2A, Stage 2B, Stage 2C, Stage 3, Stage 3A, Stage 3B, Stage 3C, Stage 4Phase 3Prostate

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2015 Cleveland Clinic. All rights reserved.